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chiatric assessment suffices, the 
Court has said, to take account 
of prisoners’ “medical interests” 
and civil liberties, as well as the 
government’s interest in prison 
safety and securing defendants’ 
competence to stand trial.
The Court’s deference to medi-
cal authority has drawn fire from 
dissenting justices on both the 
left and the right. With regard to 
the treatment of prisoners, Justice 
John Paul Stevens criticized the 
Court for withholding procedural 
safeguards, allowing psychiatrists 
to conflate therapeutic and secu-
rity purposes, and thereby enabling 
them to medicate inmates for 
“institutional convenience” under 
therapeutic cover. And Justice An-
tonin Scalia has repeatedly insist-
ed that the purposes of medicine 
are not for the profession to de-
cide. Scalia’s dissent in Gonzales 
v. Oregon (joined by Chief Justice 
John Roberts) drew a bright line 
between the profession’s techni-
cal expertise and social role. The 
latter, he says, is a matter of “pub-
lic morality,” the province of elect-
ed officials.
Will Scalia’s view gain trac-
tion? He has already brought the 
new chief justice on board, and 
many expect Justice Samuel Alito 
to concur with Scalia, Roberts, 
and Justice Clarence Thomas on 
questions of public morality, in-
cluding those that implicate med-
icine. For some, this is a chilling 
prospect, portending an era of Big 
Brother intrusion into the doctor–
patient relationship. For others, 
the promise is one of democratic 
empowerment — the making of 
moral choices by popularly cho-
sen leaders instead of technocratic 
elites.
We may soon learn whether 
Scalia’s perspective will prevail. 
The justices’ decision last month 
to consider a congressional ban 
on so-called partial-birth abortion 
poses the question of medicine’s 
authority in stark form. Six years 
ago, the Court struck down a simi-
lar state law because it lacked an 
exception for maternal medical 
need. But Congress tried an end 
run around this ruling, in the form 
of a “finding” that such abortions 
are “never medically necessary.” 
Physicians who perform abortions 
say otherwise. Lower courts have 
deferred to their views, dismiss-
ing this “finding” as unreason-
able and concluding that the con-
gressional ban is unconstitutional.
Proponents of the ban insist 
that Congress, not the medical 
profession, is entitled to deference 
on the question of clinical need. 
Abortion-rights advocates coun-
ter that pregnant women’s health 
needs are for them and their doc-
tors to determine. Central to the 
latter claim is the premise that 
the medical judgment to which a 
woman is entitled encompasses 
the moral dimensions of the de-
cision to abort. Should the former 
view prevail, public authority over 
medicine’s morality and purposes 
will greatly expand. The justices 
would do well to weigh the con-
sequences for caregivers’ ability to 
address patients’ varying needs.
Dr. Bloche is professor of law at George-
town University and a visiting fellow at the 
Brookings Institution, both in Washington, 
D.C., and adjunct professor at Bloomberg 
School of Public Health, Johns Hopkins 
University, Baltimore.
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The Growing Burden of Chronic Kidney Disease in Pakistan
Tazeen H. Jafar, M.D., M.P.H.
A Pakistani tailor, the sole breadwinner for a family of 
eight, had received diagnoses of 
type 2 diabetes and hypertension 
at 31 years of age. For the next 15 
years, although he felt well and 
visited his primary care practitioner 
twice a year, his conditions were 
poorly controlled. When he was 
46, he began to notice fatigue and 
loss of appetite. After several weeks 
of the gradual progression of these 
symptoms, the man sought med-
ical attention and was found to 
have a serum creatinine concen-
tration of 5.2 mg per deciliter 
(460 μmol per liter), a blood urea 
nitrogen concentration of 87 mg 
per deciliter (31 mmol per liter), 
an estimated glomerular filtration 
rate (GFR) of 10 ml per minute 
per 1.73 m2 of body-surface area, 
urinary albumin excretion of 1.5 g 
per day, and mildly shrunken 
kidneys. Twice-a-week sessions of 
hemodialysis were initiated, but 
the patient had to take out a loan 
to pay for them and soon was un-
able to afford to continue treat-
ment. He has been lost to follow-
up ever since.
Given pressing medical con-
cerns such as infectious diseases 
and malnutrition faced by devel-
oping countries, why should we 
even talk about chronic kidney 
disease in such places? The fact 
is that many developing countries 
are facing a silent epidemic of 
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chronic kidney disease — one 
facet of the health transition as-
sociated with industrialization. 
Moreover, by virtue of its progres-
sion to kidney failure and its as-
sociation with accelerated cardio-
vascular disease, chronic kidney 
disease has profound effects on 
morbidity, mortality, and health 
care costs, as well as important 
social implications.
Representative estimates of the 
burden of chronic kidney disease 
(defined as a decrease in the GFR 
to less than 60 ml per minute per 
1.73 m2 — half the normal rate 
— or the presence of albuminu-
ria for three or more consecutive 
months) in most developing coun-
tries are lacking. However, data 
from community-based studies in 
Pakistan reveal an alarmingly high 
burden. Approximately 15 to 20 
percent of persons 40 years of 
age or older have a reduced esti-
mated GFR.1 Although GFR esti-
mation equations have not been 
validated in Asian populations, 
such a burden is consistent with 
the high prevalence of diabetes 
and hypertension, the two main 
risk factors for chronic kidney dis-
ease. The prevalence of diabetes in 
countries of the Indian subconti-
nent (about 20 percent among per-
sons 40 years of age or older) is 
two to three times that reported 
in Western countries and is pro-
jected to triple over the next two 
decades. Evidence indicates that 
chronic kidney disease develops in 
about a third of patients with di-
abetes. The burden of hyperten-
sion is even higher — affecting 
about one third of Pakistanis 45 
years of age or older, according to 
the 1990–1994 National Health 
Survey of Pakistan.
These troubling rates are fu-
eled in part by diets high in par-
tially hydrogenated vegetable oil 
and low in fresh produce, as well 
as by increases in sedentary life-
styles in low-income communities, 
where children spend an average 
of four to six hours per day watch-
ing television. Moreover, Pakistani 
children have higher blood-pres-
sure levels, adjusted for body-mass 
index, than white children in the 
United States2 — and childhood 
levels have been shown elsewhere 
to predict levels in adulthood. 
Moreover, populations in which 
low birth weight and malnutrition 
are common may be predisposed 
to chronic diseases associated with 
weight gain.3
Despite these predisposing con-
ditions, screening for and early de-
tection of chronic kidney disease, 
particularly in high-risk patients 
with hypertension and diabetes, 
remain grossly inadequate. In part, 
this failure may be attributed to 
the fact that the health care sys-
tems in developing countries are 
geared toward providing short-
term, symptomatic treatment. But 
perhaps an even greater problem 
is that these high-risk patients 
remain largely unidentified. Al-
though the average Pakistani adult 
visits a primary care physician four 
to five times each year, 64 percent 
of adults have never had their 
blood pressure measured, and 70 
percent of patients with hyperten-
sion and 50 percent of patients 
with diabetes are unaware of their 
condition.4 Compounding the 
problem of underdetection are 
gaps in the knowledge of some 
Pakistani physicians about the 
management of hypertension and 
diabetes, which lead to under-
treatment and a lack of preventive 
measures against chronic kidney 
disease.
Against this backdrop of poor 
medical practices, patients with 
kidney failure are faced with the 
high cost of renal-replacement 
therapy. On the Indian subconti-
nent, where the per capita annual 
income (calculated in U.S. dollars) 
is about $400, the cost of dialy-
sis is about $4,000 per year. Kid-
ney transplantation costs about 
$5,000, and post-transplantation 
medications cost $2,000 annually. 
Thus, treating kidney failure is an 
unaffordable proposition for pub-
lic health systems that receive 0.8 
to 4 percent of the gross national 
product (as compared with 10 to 
15 percent in developed countries). 
These hard facts, coupled with 
the general lack of third-party 
health insurance, mean that less 
the growing burden of chronic kidney disease in pakistan
A Patient with Kidney Failure Undergoing Hemodialysis at the Aga Khan University 
Hospital, Karachi, Pakistan.
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than 10 percent of patients with 
kidney failure receive any kind 
of renal-replacement therapy. Al-
though the number of hemodial-
ysis centers is increasing in many 
regions of Pakistan, most patients 
who begin to receive dialysis die 
or stop treatment within the first 
three months because of cost con-
straints. Kidney transplantation is 
the cheaper option, but only about 
5 percent of patients with kidney 
failure receive a transplant. The 
shortage of donors is a universal 
problem, and paid organ donation 
accounts for 70 percent of all 
transplantations in Pakistan.
Clearly, programs to prevent 
chronic kidney disease and to 
treat it in the earliest stages must 
be designed and integrated into 
the existing health care infrastruc-
ture. The World Health Organi-
zation’s Innovative Care for Chron-
ic Conditions Framework provides 
a model for redesigning health 
care systems in accordance with 
local resources. The framework 
emphasizes a well-defined care 
plan, self-care, scheduled follow-
up appointments, monitoring of 
outcomes, adherence, and step-
wise treatment protocols delivered 
mainly by primary care practi-
tioners. However, increased refer-
rals from such programs, even if 
limited to patients with advanced 
disease, may place excessive de-
mands on existing nephrology 
services. At present, there are only 
about 80 formally trained nephrol-
ogists in Pakistan for a popula-
tion of about 160 million (the 
United States has more than 5000 
nephrologists for a population of 
about 300 million). Capacity-build-
ing efforts are therefore needed to 
train physicians in this specialty.
Until the public health services 
in Pakistan are developed further, 
private primary care practitioners 
will continue to be the frontline 
caregivers in Pakistan. These phy-
sicians should be required — 
perhaps even as a prerequisite for 
the renewal of licensure — to 
participate in continuing medical 
education programs regarding the 
management of hypertension, dia-
betes, and chronic kidney disease.
Ideally, developing countries 
would have access to ample re-
sources to set up large-scale, in-
tegrated programs for the pre-
vention and treatment of chronic 
diseases, as well as dialysis and 
transplantation units for patients 
with kidney failure. But in reality, 
such resources are unlikely to be 
found. Low-income countries must 
therefore shift their emphasis from 
renal-replacement therapy to more 
cost-effective preventive services, 
recognizing that questions of so-
cial justice and equity will in-
evitably arise. Since Pakistan’s 
resources are currently being di-
rected toward the rehabilitation 
of survivors of October’s earth-
quake, it is unlikely that more re-
sources will be allocated for the 
treatment or prevention of chron-
ic kidney disease anytime soon. 
International agencies must there-
fore recognize that without urgent 
attention to the problem, the ad-
verse consequences of hyperten-
sion, diabetes, and chronic kidney 
disease will bring untold misery 
to the next generation of inhab-
itants of the Indian subcontinent 
— who represent one sixth of the 
world’s population.
Dr. Jafar is the head of the section of ne-
phrology, director of the clinical epidemiol-
ogy unit, and an associate professor of 
medicine and community health sciences 
at Aga Khan University, Karachi, Pakistan, 
and an adjunct faculty member at Tufts–
New England Medical Center, Boston.
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Chronic Kidney Disease in the Developing World
Rashad S. Barsoum, M.D.
The attention being paid glob-ally to chronic kidney disease 
is attributable to five factors: the 
rapid increase in its prevalence, 
the enormous cost of treatment, 
recent data indicating that overt 
disease is the tip of an iceberg of 
covert disease, an appreciation of 
its major role in increasing the risk 
of cardiovascular disease, and the 
discovery of effective measures to 
prevent its progression. These fac-
tors render chronic kidney disease 
an important focus of health care 
planning even in the developed 
world, but the problems they delin-
eate in the developing world are far 
more challenging. Some 85 per-
cent of the world’s population live 
in low-income or middle-income 
countries, where the clinical, epi-
demiologic, and socioeconomic ef-
fects of the disease are expected to 
be the greatest.
Data from the United States 
suggest that for every patient with 
end-stage renal disease (ESRD), 
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